Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-147-5 | CAS number: 61788-85-0 1 - 6.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In an Ames test the substance was tested in Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and E. coli strain WP2uvrA in presence and absence of metabolic activation. No increase in mutant frequency was reported in any of the strains tested both in presence and absence of metabolic activation. The substance is considered to be non-mutagenic under the conditions of this test.
The substance was tested in the L5178Y TK +/- Mouse Lymphoma Assay according to OECD 490 up to precipitation level. Exposure was either 4 hours (with and without metabolic activation) or 24 hours (without metabolic activation). No increase in the mutant frequency at the TK +/- locus was reported (evaluation with the Global Evaluation Factor (GEF) of 126 E-06). Therefore it is concluded that the substance is non-mutagenic in this assay.
Duplicate cultures of human lymphocytes, treated with the substance, were evaluated for chromosome aberrations at up to four dose levels (maximum dose 160 mg/mL, lowest precipitating level), together with vehicle and positive controls in presence of metabolic activation (4 hours) and in absence of metabolic activation (4 and 24 hours). The substance did not demonstrate any marked toxicity and did not induce any statistically significant increases in the frequency of cells with aberrations and was considered to be non-clastogenic to human lymphocytes in vitro.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 June 2017 to 06 August 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine/tryptophan
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: University of California, Berkeley, on culture discs, on 04 August 1995, • British Industrial Biological Research Association, on a nutrient agar plate, on 17 August 1987.
- Methods for maintenance in cell culture if applicable: stored at -196 °C in a Statebourne liquid nitrogen freezer, model SXR 34 - Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital/beta-naphthaflavone induced rat liver S9 (Lot No. PB/NF S9 30 June 2017 )
- Test concentrations with justification for top dose:
- Test 1 (plate incorporation): 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Test 2 (pre-incubation): 15, 50, 150, 500, 1500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: substance is insoluble in water and DMSO, completely soluble in acetone at 100 mg/L - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone (in pre-incubation test 0.05 mL in final test solution)
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: exp 1 plate incorporation; exp 2 preincubation
DURATION
- Preincubation period: 30 min at 37 ± 3 °C
- Exposure duration: 48 h at 37 ± 3 °C
NUMBER OF REPLICATIONS: 3/concentration
DETERMINATION OF CYTOTOXICITY
- Method: visible reduction in the growth of the bacterial background lawn - Evaluation criteria:
- a substance is considered positive when:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)). - Statistics:
- Dunnetts Regression Analysis
- Key result
- Species / strain:
- other: TA1535, TA1537, TA98, TA100 and WP2uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: at 1500 and 5000 ug/plate a slight film of the substance was seen (not preventing scoring)
- Conclusions:
- Based on the findings in this test the substance is considered non-mutagenic in bacteria
- Executive summary:
In an Ames test the substance was tested in Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and E. coli strain WP2uvrA in presence and absence of metabolic activation. No increase in mutant frequency was reported in any of the strains tested both in presence and absence of metabolic activation. The substance is considered to be non-mutagenic under the conditions of this test.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03 August 2017 to 17 November 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- The Japanese Ministry of Health, Labour and Welfare (MHLW), Ministry of Economy Trade and Industry (METI), and Ministry of the Environmental (MOE) Guidelines of 31 March 2011
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- NA
- Species / strain / cell type:
- lymphocytes: human peripheral lymphocytes
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: human peripheral lymphocytes
- Suitability of cells: standard cells (checked for exposure to high levels of radiation or hazardous chemicals and not knowingly recently suffered from a viral infection)
- Cell cycle length, doubling time or proliferation index: AGT 16 hours
- Sex, age and number of blood donors if applicable: Preliminary Toxicity Test: female, aged 30 years; Main Experiment: female, aged 28 years
- Whether whole blood or separated lymphocytes were used if applicable: fresh heparinized whole blood
- Methods for maintenance in cell culture: grown in Eagle's minimal essential medium with HEPES buffer (MEM), supplemented “in-house” with L-glutamine, penicillin/streptomycin, amphotericin B and 10 % foetal bovine serum (FBS), at approximately 37 ºC with 5 % CO2 in humidified air
- Modal number of chromosomes: 44-48
- Normal (negative control) cell cycle time: 16 hours
MEDIA USED
- Type and identity of media including CO2 concentration: MEM at approximately 37 ºC with 5 % CO2
- Properly maintained: yes - Cytokinesis block (if used):
- demecolcine (Colcemid 0.1 µg/mL) 2.5 hours before the required harvest time.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from rat livers induced with phenobarbital/beta-naphthoflavone
- Test concentrations with justification for top dose:
- Exposure Group Final concentration of
4(20)-hour without S9 0*, 5, 10, 20*, 40*, 80*, 160, MMC 0.4*
4(20)-hour with S9 (2%) 0*, 5, 10, 20*, 40*, 80*, 160, CP 4*
24-hour without S9 0*, 5, 10, 20*, 40*, 80*, 160, MMC 0.1*
* Dose levels selected for metaphase analysis - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Acetone (99.75 % in 505 µl aliquots; maximum achieved dosing concentration 2500 µg/mL)
- Justification for choice of solvent/vehicle: insoluble in culture medium at 50 mg/mL and dimethyl sulphoxide at 500 mg/mL but soluble in acetone at 500 mg/mL - Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- DURATION
- pre-incubation: 48 hours at approximately 37 ºC, 5% CO2 in humidified air
- Exposure duration: 4 hour with and without metabolic activation, 24 hours without metaboliv activation at approximately 37 ºC, 5% CO2 in humidified air
- Expression time (cells in growth medium): 4 hour tests: 20 hours at approximately 37 ºC, 5% CO2 in humidified air
SPINDLE INHIBITOR: Mitosis was arrested by addition of demecolcine (Colcemid 0.1 µg/mL) 2.5 hours before the required harvest time. After incubation with demecolcine, the cells were centrifuged, the culture medium was drawn off and discarded, and the cells re-suspended in 0.075M hypotonic KCl. After approximately fourteen minutes (including centrifugation), most of the hypotonic solution was drawn off and discarded. The cells were re-suspended and then fixed by dropping the KCl cell suspension into fresh methanol/glacial acetic acid (3:1 v/v). The fixative was changed at least three times and the cells stored at approximately 4 ºC to ensure complete fixation prior to slide preparation.
STAIN: Giemsa
NUMBER OF REPLICATIONS: 2/concentration
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: The lymphocytes were re-suspended in several mL of fresh fixative before centrifugation and re-suspension in a small amount of fixative. Several drops of this suspension were dropped onto clean, wet microscope slides and left to air dry. Each slide was permanently labeled with the appropriate identification data.
When the slides were dry they were stained in 5% Giemsa for 5 minutes, rinsed, dried and a cover slip applied using mounting medium.
NUMBER OF CELLS EVALUATED: 2000/concentration for mitotic index
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE : 300 consecutive well-spread metaphases from each concentration were counted (150 per duplicate)
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: cells with 69 chromosomes or more were scored as polyploid cells
- Determination of endoreplication: recorded separately and included in the polyplod cell total - Rationale for test conditions:
- standard according to the guidance
- Evaluation criteria:
- •The frequency of cells with structural chromosome aberrations (excluding gaps) in the vehicle control cultures was within the laboratory historical control data range
•All the positive control chemicals induced a positive response (p≤0.01) and demonstrated the validity of the experiment and the integrity of the S9-mix
•The study was performed using all three exposure conditions using a top concentration which meets the requirements of the current testing guideline
•The required number of cells and concentrations were analyzed - Statistics:
- Fisher's Exact test (p<0.05)
- Key result
- Species / strain:
- lymphocytes: human peripheral lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: 7.18 -7.32
- Effects of osmolality: 309 -347 mOs
- Evaporation from medium: none
- Water solubility: see vehicle selection
- Precipitation: yes at 80 ug/mL in all tests
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: available (all findings were within historical control values)
- Negative (solvent/vehicle) historical control data: available (all findings were within historical control values)
ADDITIONAL INFORMATION ON CYTOTOXICITY: none (29% decrease of mitotic index in 24 h test at 80 ug/mL) - Conclusions:
- The substance is considered not clastogenic under the conditions of the test
- Executive summary:
Duplicate cultures of human lymphocytes, treated with the test item, were evaluated for chromosome aberrations at up to four dose levels, together with vehicle and positive controls. In this study, three exposure conditions were investigated;4 hours exposure in the presence of an induced rat liver homogenate metabolizing system (S9), at a 2% final concentration with cell harvest after a 20-hour expression period, 4 hours exposure in the absence of metabolic activation (S9) with a 20-hour expression period and a 24-hour exposure in the absence of metabolic activation.
The dose levels used in the Main Experiment were selected using data from the preliminary toxicity test where the results indicated that the maximum concentration should be limited by precipitate. The dose levels selected for the Main Test were as follows:
Group
Final concentration of substance evaluated
4(20)-hour without S9
0, 5,10, 20, 40, 80, 160
4(20)-hour with S9 (2%)
0, 5,10, 20, 40, 80, 160
24-hour without S9
0, 5,10, 20, 40, 80, 160
All vehicle (Acetone) controls had frequencies of cells with aberrations within the range expected for normal human lymphocytes.
All the positive control items induced statistically significant increases in the frequency of cells with aberrations. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The test item did not demonstrate any marked toxicity and did not induce any statistically significant increases in the frequency of cells with aberrations, using a dose range that included a dose level that was the lowest precipitating dose level.
The test item,was considered to be non-clastogenic to human lymphocytes in vitro.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 November 2017 to 19 December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Target gene:
- TK
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED: L5178Y TK+/- 3.7.2c mouse lymphoma cell line
- Source of cells: MRC Cell Mutation Unit at the University of Sussex, Brighton, UK
- Cell cycle length:ca 12 hours
- Methods for maintenance in cell culture if applicable: stored in liquid nitrogen at approximately -196°C
MEDIA USED
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically 'cleansed' against high spontaneous background: yes, before freezing - Additional strain / cell type characteristics:
- other: TK+/-
- Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital/beta-naphthaflavone induced rat liver S9
- Test concentrations with justification for top dose:
- 4 h and 24 h exposure: 2.5, 5, 10, 20, 40 and 80 µg/mL
Top dose based on presence of precipitate - Vehicle / solvent:
- acetone (acetone is toxic to cells at 0.5% of total volume, therefore the substance was formulated at 500 mg/mL and dosed at 0.5% to give the maximum achievable dose level of 2500 µg/mL to be used in the pre-test).
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- A pretest was conducted on cell cultures at 5 x 10 E5 cells/mL, using a 4-hour exposure period both with and without metabolic activation (S9), and at 1.5 x 10E5 cells/mL using a 24-hour exposure period without S9. The dose range was set at 1.25 to 320 µg/mL. After exposure cells were washed twice, resuspended and counted. The cultures were serially diluted to 2 x 10E5 cells/mL. and incubated at 37 C with 5% CO2 in air and sub-cultured after 24 hours. After a further 24 hours the cultures were counted to assess Suspension Growth (SG)
In the main study exposures were performed in duplicate (A + B), both with and without metabolic activation (2% S9 final concentration) in R0 or R10 medium (total volume to 20 mL). The solutions were incubated at 37°C for 4 or 24 hours with continuous shaking. the initial cell number was 1 x 10E6 cells/mL for 4 hour exposures and 0.3 x 10E6 cells/mL for 24 hour exposure.
At the end of the treatment period, for each experiment, the cells were washed twice, resuspended in R20 medium and incubated at 37°C with 5% CO2 (subcultured and counted every 24 hours -> Relative Suspension Growth (%RSG)) for 2 days.
On Day 2 of the experiment, the cells were counted again, diluted to 10E4 cells/mL and plated for mutant frequency (2000 cells/well) in selective medium containing 4 µg/mL 5-trifluorothymidine (TFT) in 96-well microtitre plates.On this dayadditional cells were diluted to 10 cells/mL and plated (2 cells/well) for viability (%V) in non-selective medium.
Microtitre plates were scored using a magnifying mirror box after ten to twelve days incubation at 37°C with 5% CO2 in air. These plates were also scored for the presence of large and small colonies. - Evaluation criteria:
- Providing that all acceptability criteria are fulfilled, a test chemical is considered to be clearly positive if, in any of the experimental conditions examined, the increase in MF above the concurrent background exceeds the GEF and the increase is concentration related (e.g., using a trend test). The test chemical is then considered able to induce mutation in this test system.
Providing that all acceptability criteria are fulfilled, a test chemical is considered to be clearly negative if, in all experimental conditions examined there is no concentration related response or, if there is an increase in MF, it does not exceed the GEF. The test chemical is then considered unable to induce mutations in this test system. - Statistics:
- Mutant 240C by York Electronic Research, which follows the statistical guidelines recommended by the UKEMS (Robinson W D et al., 1989).
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no (7.23-7.33)
- Effects of osmolality: no (277-287 mOs)
- Precipitation:
main study: onset at 80 µg/mL in all cultures
RANGE-FINDING/SCREENING STUDIES: no cytotoxicity, onset of precipitate at at 40 µg/mL in the 4-hour culture with metabolic activation and the 24 h culture and at 80 µg/mL in the 4-hour culture without metabolic activation
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%) are reported in an annex to the report - Remarks on result:
- other: 4 hour exposure
- Conclusions:
- The substance is considered non-mutagenic in the L5178Y TK +/- Mouse Lymphoma Assay
- Executive summary:
The substance was tested in the L5178Y TK +/- Mouse Lymphoma Assay according to OECD 490 up to precipitation level. Exposure was either 4 hours (with and without metabolic activation) or 24 hours (without metabolic activation). No increase in the mutant frequency at the TK +/- locus was reported (evaluation with the Global Evaluation Factor (GEF) of 126 E-06). Therefore it is concluded that the substance is non-mutagenic in this assay.
Referenceopen allclose all
details see attached document
Treatment (µg/ml) |
4-hours -S-9 Treatment |
|
Treatment (µg/ml) |
4-hours +S-9 Treatment
|
|
Treatment (µg/ml) |
|
24-hours -S-9 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
%RSG |
RTG |
MF§ |
|
|
|
%RSG |
RTG |
MF§ |
|
|
|
%RSG |
RTG |
MF§ |
0 |
|
100 |
1.00 |
143.34 |
|
0 |
|
100 |
1.00 |
85.13 |
|
0 |
|
100 |
1.00 |
204.05 |
0.63 |
Ø |
94 |
|
|
|
1.25 |
Ø |
99 |
|
|
|
1.25 |
Ø |
98 |
|
|
1.25 |
Ø |
91 |
|
|
|
2.5 |
|
89 |
0.88 |
100.48 |
|
2.5 |
|
104 |
1.19 |
192.91 |
2.5 |
|
89 |
0.85 |
162.50 |
|
5 |
|
90 |
0.98 |
94.87 |
|
5 |
|
116 |
1.18 |
210.26 |
5 |
|
75 |
0.67 |
168.38 |
|
10 |
|
96 |
1.13 |
97.74 |
|
10 |
|
172 |
1.79 |
181.74 |
10 |
|
67 |
0.65 |
154.48 |
|
20 |
|
83 |
1.25 |
63.85 |
|
20 |
|
159 |
1.68 |
174.76 |
20 |
|
76 |
0.70 |
177.80 |
|
40 |
|
84 |
1.33 |
63.71 |
|
40 |
|
146 |
1.69 |
179.75 |
40 |
|
73 |
0.68 |
174.80 |
|
80 |
|
97 |
1.12 |
93.82 |
|
80 |
|
135 |
1.66 |
168.08 |
80 |
|
70 |
0.81 |
132.98 |
|
160 |
Ø |
90 |
|
|
|
160 |
Ø |
111 |
|
|
|
MF threshold for a positive response = 269.34 |
|
|
MF threshold for a positive response = 211.13 |
|
|
MF threshold for a positive response = 330.05 |
|||||||||
EMS |
|
|
|
|
|
CP |
|
|
|
|
|
EMS |
|
|
|
|
400 |
|
57 |
0.48 |
1094.30 |
|
1.5 |
|
73 |
0.48 |
880.23 |
|
150 |
|
79 |
0.60 |
1847.41 |
§ Positive wells per tray, 96 wells plated
Proportion small colony mutants
Treatment (µg/ml) |
4-hours -S-9 Treatment |
4-hours +S-9 Treatment
|
24-hours -S-9 |
0 |
0.43 |
0.35 |
0.53 |
2.5 |
0.48 |
0.54 |
0.54 |
5 |
0.43 |
0.33 |
0.48 |
10 |
0.44 |
0.24 |
0.54 |
20 |
0.45 |
0.30 |
0.36 |
40 |
0.44 |
0.47 |
0.49 |
80 |
0.47 |
0.38 |
0.39 |
Positive control |
0.50 |
0.84 |
0.51 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the available information no classification for mutagenicity is necessary according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.